Lantheus Holdings, Inc. (LNTH)
86.15
+0.33
(+0.38%)
USD |
NASDAQ |
May 06, 16:00
89.00
+2.85
(+3.31%)
Pre-Market: 08:19
Lantheus Holdings Free Cash Flow : 348.64M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Anika Therapeutics, Inc. | 1.039M |
| BioCryst Pharmaceuticals, Inc. | 327.41M |
| Azenta, Inc. | 28.72M |
| Plus Therapeutics, Inc. | -20.84M |
| BioStem Technologies, Inc. | 6.589M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 90.18M |
| Cash from Investing (Quarterly) | -11.51M |
| Cash from Financing (Quarterly) | -100.79M |
| Free Cash Flow Per Share (Quarterly) | 1.146 |
| Free Cash Flow to Equity (Quarterly) | 72.18M |
| Free Cash Flow to Firm (Quarterly) | 79.88M |
| Free Cash Flow Yield | 5.87% |